Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Structural & Molecular Biology|May 3, 2016
Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR traffickingChiara Francavilla, Moreno Papetti, Kristoffer T G Rigbolt, et al.
Science Signaling|November 22, 2018
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastomaKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Molecular & Cellular Proteomics : MCP|July 16, 2025
Multi-omics Characterization of Acquired Olaparib Resistance in BRCA1 and BRCA2 Mutant Breast Cancer Cell LinesHolda A Anagho-Mattanovich, Meeli Mullari, Matthias Anagho-Mattanovich, et al.
Acta Neuropathologica Communications|August 16, 2022
Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Aβ oligomers to ratsEva Baerends, Katia Soud, Jonas Folke, et al.
Journal for Immunotherapy of Cancer|October 2, 2024
Gal-3 blocks the binding between PD-1 and pembrolizumabStinne Ravn Greisen, Mia Bendix, Morten Aagaard Nielsen, et al.
Science Signaling|April 30, 2015
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiationKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Scientific Reports|November 21, 2024
Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R levelSarah Hyllekvist Jørgensen, Kristina Bennet Emdal, Anna-Kathrine Pedersen, et al.
JCI Insight|April 4, 2023
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritisDimitra Papadopoulou, Fani Roumelioti, Christos Tzaferis, et al.
Molecular & Cellular Proteomics : MCP|December 20, 2019
Molecular Basis of the Mechanisms Controlling MASTLDario Hermida, Gulnahar B Mortuza, Anna-Kathrine Pedersen, et al.
European Journal of Immunology|February 26, 2026
Curbing Autoimmunity: A New Fab Fragment Targeting CD40-CD40L Halts B-Cell Activation and DifferentiationKathrine Pedersen, Kenneth Green, Emil L Kristoffersen, et al.
Pageof 3